{
    "2018-11-28": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie (ABBV) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Gains",
                        "Lags",
                        "Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "3 Themes To Watch As Biopharmas 'Bring Some Excitement' In Blood Cancer",
                "features": {
                    "keywords": [
                        "Biopharmas",
                        "Excitement",
                        "Blood Cancer"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "3 Top Stocks With High Dividend Yields",
                "features": {
                    "keywords": [
                        "Top Stocks",
                        "High Dividend Yields"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividends"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Vertex's (VRTX) Triple Combo Cystic Fibrosis Studies Succeed",
                "features": {
                    "keywords": [
                        "Vertex",
                        "Triple Combo",
                        "Cystic Fibrosis",
                        "Studies Succeed"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}